Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06801236
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
- Locations
-
- University of California San Diego, Moores Cancer Center La Jolla, California, United States
- Moffitt Cancer Center, Tampa Tampa, Florida, United States
- University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Harvard Medical School-Massachusetts General Hospital Boston, Massachusetts, United States